Pittsburgh

‘Game changer’ cancer treatment eliminates 6 of 7 tumors for Kentucky man – Pittsburgh, Pennsylvania

Pittsburgh, Pennsylvania 2020-11-21 22:03:00 –

Cancer patients with a survival time of 6 months say that experimental treatment has extended their lifespan. Last August, 46-year-old Tony Burton was diagnosed with stage 4 lung cancer. His first doctor said his prognosis was dire. “I refused to believe it,” said Dr. Jason Chesney of the Brown Cancer Institute at the University of Louisville, Barton’s second doctor, giving him hope. Chesnee has provided Burton with the opportunity to participate in medical trials that include treatments that have not yet been approved by the Food and Drug Administration. Chesnee explains: “This is a cell-based immunotherapy. It is the only site in the region and state that offers such cell-based therapies. It is called tumor-infiltrating lymphocytes.” It’s not a procedure like bone marrow transplantation. The doctor removes part of the tumor and teaches existing cells to fight the tumor. The cells are then returned to the patient’s body. Burton says he has removed six tumors so far. “As of today, there is only one tumor left. I hope it will disappear in the next scan,” he said. Chesnee said current immunotherapy treatments reduced cancer deaths by 25%. He believes these advances in cell technology can save an additional 25%. He calls this a game changer. I have to get treatment. ” Burton was the first lung cancer patient to be treated at the University of Louisville, and due to his success, he is probably not the last. He hopes the FDA will officially approve it next year.

A cancer patient who has been given a lifespan of six months says that experimental treatment has extended his lifespan.

Last August, 46-year-old Tony Burton was diagnosed with stage 4 lung cancer. His first doctor said his prognosis was harsh.

“He told me I needed to get things in order, and I probably had four to six months to live,” Burton said. “I refused to believe it.”

Barton’s second doctor, Dr. Jason Chesney of the Brown Cancer Institute at the University of Louisville, gave him hope. Chesnee has provided Burton with the opportunity to participate in medical trials that include treatments that have not yet been approved by the Food and Drug Administration.

Chesnee explains: “This is a cell-based immunotherapy. It is the only site in the region and state that offers such cell-based therapies. It is called tumor-infiltrating lymphocytes.”

It’s not a drug, but rather a procedure — it’s like a bone marrow transplant. The doctor removes part of the tumor and teaches existing cells to fight the tumor. The cells are then returned to the patient’s body.

Burton said he had resected six tumors so far.

“As of today, there is only one tumor left, and I hope it will disappear in the next scan,” he said.

Current immunotherapy treatment has reduced cancer deaths by 25%, Chesnee said. He believes these advances in cell technology can save an additional 25%.

He calls it a game changer.

“I have 10 to 20 patients who were told to’go home and die’, and now they are living a normal life without any treatment,” Chesnee said. ..

Burton was the first lung cancer patient to be treated at the University of Louisville, and due to his success, he is probably not the last.

Chesnee said the treatment has been proven in patients with lymphoma and is expected to be formally approved by the FDA next year.

‘Game changer’ cancer treatment eliminates 6 of 7 tumors for Kentucky man Source link ‘Game changer’ cancer treatment eliminates 6 of 7 tumors for Kentucky man

Back to top button